HT
MRNA icon

Heritage Trust’s Moderna MRNA Stock Holding History

Heritage Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,563
Closed -$311K – 262
2023
Q2 		$311K Sell
2,563
-1,825
-42% -$243K 0.05% 220
2023
Q1 		$674K Sell
4,388
-152
-3% -$25.1K 0.11% 155
2022
Q4 		$815K Buy
4,540
+396
+10% +$64.8K 0.13% 143
2022
Q3 		$490K Sell
4,144
-508
-11% -$77.1K 0.09% 176
2022
Q2 		$665K Buy
4,652
+807
+21% +$115K 0.11% 161
2022
Q1 		$662K Buy
3,845
+432
+13% +$72.7K 0.09% 164
2021
Q4 		$867K Buy
3,413
+101
+3% +$29.5K 0.11% 147
2021
Q3 		$1.27M Buy
3,312
+426
+15% +$157K 0.18% 119
2021
Q2 		$678K Buy
2,886
+317
+12% +$56.7K 0.1% 155
2021
Q1 		$336K Buy
+2,569
New +$372K 0.05% 201

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Heritage Trust's MRNA Position: Q3 2023 in Review

Heritage Trust sold out of Moderna (MRNA) in Q3 2023, closing a stake of 2,563 shares — an estimated $311K sold.

Heritage Trust first reported a position in MRNA in Q1 2021 and held it in 10 quarters. The position peaked at $1.27M in Q3 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Heritage Trust reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Heritage Trust sold 2,563 Moderna shares in Q3 2023, an estimated $311K.
  • Heritage Trust first reported a position in Moderna in Q1 2021 and held it in 10 quarters.
  • Heritage Trust's Moderna position peaked at $1.27M in Q3 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Heritage Trust's 13F filing for Q3 2023, filed 8 Nov 2023.